Rhenman & Partners Asset Management AB

Source: SEC Form 13F · as of Mar 2026

Rhenman & Partners Asset Management AB holds 57 biotech & pharma companies tracked by BioSniper, totaling $554.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

57

Total value held

$554.9M

CompanySharesValue
REGNREGENERON PHARMACEUTICALS, INC.48,100$37.2M
LLYELI LILLY & Co33,715$31.0M
INSMINSMED Inc159,760$26.1M
GILDGILEAD SCIENCES, INC.167,750$23.4M
BIIBBIOGEN INC.109,100$20.0M
VRTXVERTEX PHARMACEUTICALS INC / MA43,485$19.4M
ALHCAlignment Healthcare Inc.1,053,450$18.6M
CORCencora Inc.52,375$16.5M
ABBVAbbVie Inc.71,575$15.6M
MCKMcKesson Corporation16,850$14.6M
JAZZJazz Pharmaceuticals plc75,890$14.3M
GHGuardant Health Inc.145,000$13.4M
NBIXNEUROCRINE BIOSCIENCES INC100,841$13.3M
MDGLMADRIGAL PHARMACEUTICALS, INC.24,050$12.6M
UNHUnitedHealth Group Incorporated Common Stock (DE)45,500$12.3M
PRCTPROCEPT BioRobotics Corporation475,000$11.9M
BMRNBIOMARIN PHARMACEUTICAL INC207,000$11.7M
ABTABBOTT LABORATORIES112,000$11.5M
ALNYALNYLAM PHARMACEUTICALS, INC.34,465$11.4M
RPRXRoyalty Pharma plc233,000$11.2M
AXSMAxsome Therapeutics, Inc.63,800$10.8M
ADPTAdaptive Biotechnologies Corp720,000$10.0M
ELVElevance Health Inc.32,300$9.5M
ARWRARROWHEAD PHARMACEUTICALS, INC.144,500$9.1M
IQVIQVIA Holdings Inc.53,000$9.0M
SNDXSyndax Pharmaceuticals Inc379,250$8.9M
MIRMMirum Pharmaceuticals, Inc.92,605$8.6M
IDYAIDEAYA Biosciences, Inc.255,500$8.5M
NUVLNuvalent, Inc.81,200$8.3M
OSCROscar Health Inc.660,000$7.6M
IOVAIOVANCE BIOTHERAPEUTICS, INC.2,055,327$7.2M
MLYSMineralys Therapeutics, Inc.263,071$7.1M
IONSIONIS PHARMACEUTICALS INC92,900$7.0M
DNTHDianthus Therapeutics, Inc. /DE/81,627$6.9M
BBIOBridgeBio Pharma, Inc.90,600$6.7M
APGEApogee Therapeutics, Inc.75,000$6.3M
GPCRStructure Therapeutics Inc.128,100$6.2M
CAHCardinal Health Inc.27,000$5.7M
AMGNAMGEN INC15,200$5.3M
VKTXViking Therapeutics, Inc.160,000$5.2M
NRIXNurix Therapeutics, Inc.313,500$4.9M
ALKSAlkermes plc.133,250$4.7M
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.26,000$4.5M
MLTXMoonLake Immunotherapeutics239,500$4.5M
KRYSKrystal Biotech, Inc.16,675$4.3M
NKTRNEKTAR THERAPEUTICS59,000$4.2M
DNLIDenali Therapeutics Inc.199,000$3.8M
RLAYRelay Therapeutics, Inc.360,000$3.6M
SIONSionna Therapeutics, Inc.87,500$3.5M
STOKStoke Therapeutics, Inc.83,000$2.7M
ESPREsperion Therapeutics, Inc.985,000$2.7M
IMCRImmunocore Holdings plc85,724$2.6M
OCULOCULAR THERAPEUTIX, INC305,000$2.6M
VCELVericel Corp70,000$2.3M
KURAKura Oncology, Inc.271,500$2.2M
XENEXenon Pharmaceuticals Inc.28,000$1.6M
CMPXCompass Therapeutics, Inc.115,113$609K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Rhenman & Partners Asset Management AB — Biotech 13F Holdings & Portfolio | BioSniper